Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?
View Full Paper
Ask AI
Bookmark
Share
Abstract
Professor of Psychiatry, University of Pittsburgh Director, Law and Psychiatry Program, WPIC Director, Adult Psychiatric Services, WPIC
Discussion
No takes yet. Share an insight, caveat, or question.